Inherited thrombocytopenias (ITs) are a heterogeneous group of syndromic and non syndromic diseases caused by mutations affecting different genes. Alterations of ACTN1, the gene encoding for α-actinin 1, have recently been identified in a few families as responsible for a mild form of IT (ACTN1-related thrombocytopenia; ACTN1-RT). To better characterize this disease, we screened ACTN1 in 128 probands and found ten (eight novel) missense heterozygous variants in 11 families. Combining bioinformatics, segregation, and functional studies we demonstrated that all but one amino acid substitution had deleterious effects. The clinical and laboratory findings of 31 affected individuals confirmed that ACTN1-RT is a mild macrothrombocytopenia with low risk of bleeding. Low reticulated platelet counts and only slightly increased serum thrombopoietin levels indicated that the latest phases of megakaryopoiesis were affected. Given its relatively high frequency in our cohort (4.2%), ACTN1-RT has to be taken into consideration in the differential diagnosis of ITs.
Bottega R, Marconi C, Faleschini M, Baj G, Cagioni C, Pecci A, et al. (2015). ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. BLOOD, 125(5), 869-872 [10.1182/blood-2014-08-594531].
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization.
MARCONI, CATERINA;SERI, MARCO;
2015
Abstract
Inherited thrombocytopenias (ITs) are a heterogeneous group of syndromic and non syndromic diseases caused by mutations affecting different genes. Alterations of ACTN1, the gene encoding for α-actinin 1, have recently been identified in a few families as responsible for a mild form of IT (ACTN1-related thrombocytopenia; ACTN1-RT). To better characterize this disease, we screened ACTN1 in 128 probands and found ten (eight novel) missense heterozygous variants in 11 families. Combining bioinformatics, segregation, and functional studies we demonstrated that all but one amino acid substitution had deleterious effects. The clinical and laboratory findings of 31 affected individuals confirmed that ACTN1-RT is a mild macrothrombocytopenia with low risk of bleeding. Low reticulated platelet counts and only slightly increased serum thrombopoietin levels indicated that the latest phases of megakaryopoiesis were affected. Given its relatively high frequency in our cohort (4.2%), ACTN1-RT has to be taken into consideration in the differential diagnosis of ITs.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
